Anteris Technologies Global Corp. (AVR) fundamentals score
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Healthcare · Listed on NASDAQ
Overall: 4.3 out of 10, Weak long-term fundamentals
- Growth: 4.9/10
- Profitability: 1.8/10
- Financial health: 6.8/10
- Earnings quality: 7.0/10
- Valuation: 1.5/10
Scores are calculated from Anteris Technologies Global Corp.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10